Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diabetic Kidney Disease (DKD): early-phase trial registry
1 of 2 indexed Diabetic Kidney Disease (DKD) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Diabetic Kidney Disease (DKD): 2 US clinical trials tracked, 1 recruiting.
Diabetic Kidney Disease (DKD) is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Rubix LS, running 1 of these trials.
Enrollment posture brief
Registry condition diabetic-kidney-disease-dkd
OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Diabetic Kidney Disease (DKD) lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diabetic Kidney Disease (DKD) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diabetic Kidney Disease (DKD) is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Regeneron Pharmaceuticals
NCT07271186
Rubix LS Diabetic Kidney Disease (DKD) Registry Study
Rubix LS
NCT07348718
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Diabetic Kidney Disease (DKD) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diabetic Kidney Disease (DKD) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diabetic Kidney Disease (DKD) page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Diabetic Kidney Disease (DKD) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Rubix LS sponsors the most Diabetic Kidney Disease (DKD) trials on record, review their full trial history before evaluating a specific study. See Rubix LS's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetic Kidney Disease (DKD) condition card totals 2 registered trials; most-linked intervention Kidney-Protective Therapies Used in Routine Care; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.